SOUTH KOREA · OPENDART
Qurient Co., Ltd.
큐리언트 · 115180 · KOSDAQ · Healthcare · Biotechnology
Score
Not ranked: no net buying on the exchange by an individual insider in the last 180 days.
Insiders' buying price vs the latest close
Insiders paid 37,370.50 KRW a share on average (2 purchase lines, 1 buyer, 2026-03-30 – 2026-03-31). The close on 2026-10-16 was 45.2% below that price.
The latest purchase (2026-03-31) was at 36,741.00 KRW; the close was 44.3% below that price.
Prices paid are weighted by shares and taken from the filings; dividends are not counted. Not scored.
Insider trades on the exchange
Purchases and sales on the exchange in the last 12 months. The filing gives the settlement date; the trade date is two trading days earlier.
| Trade date | Insider | Role | Trade | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| 2026-03-31 | Kim Sungwoo | Auditor | Bought on the exchange | 1,000 | ₩36,741 | ₩36.7M | DART ↗ |
| 2026-03-30 | Kim Sungwoo | Auditor | Bought on the exchange | 1,000 | ₩38,000 | ₩38.0M | DART ↗ |
| 2026-03-24 | Kim Jaeseung | Vice president | Sold on the exchange | 1,968 | ₩40,627 | ₩80.0M | DART ↗ |
| 2026-03-23 | Kim Jaeseung | Vice president | Sold on the exchange | 2,032 | ₩42,174 | ₩85.7M | DART ↗ |
Other changes in holdings · 41
Option exercises, grants, new shares, inheritance, gifts, off-exchange trades and trades by companies and funds. Not counted in the score.
| Date | Insider | Role | Reason | Shares | Filing |
|---|---|---|---|---|---|
| 2026-07-29 | Chang Eyun Yu | Vice president | Stock options(+) | 10,000 | DART ↗ |
| 2026-04-30 | Chang Eyun Yu | Vice president | Stock options(+) | 12,000 | DART ↗ |
| 2026-04-29 | Lim Hyunjin | Senior managing director | Stock options(+) | 17,000 | DART ↗ |
| 2026-04-29 | Kim Jeong Jun | Managing director | Stock options(+) | 11,564 | DART ↗ |
| 2026-04-29 | Heo Tae Suk | Director | Stock options(+) | 17,000 | DART ↗ |
| 2026-03-25 | Nam Kiyean | CEO | Stock options(+) | 20,000 | DART ↗ |
| 2026-03-25 | Kim Jaeseung | Vice president | Stock options(+) | 6,000 | DART ↗ |
| 2026-02-23 | Byung Girl Rhee | Non-executive director | Acquisition of shares upon exercise of call option(+) | 15,000 | DART ↗ |
| 2026-02-23 | Cho Yong Joon | Non-executive director | Acquisition of shares upon exercise of call option(+) | 104,000 | DART ↗ |
| 2026-02-23 | Dongkoo Bio&Pharma Co.,Ltd | 10% shareholder | Acquisition of shares upon exercise of call option(+) | 488,242 | DART ↗ |
| 2026-01-29 | Lim Hyunjin | Managing director | Stock options(+) | 5,000 | DART ↗ |
| 2026-01-29 | Kim Jeong Jun | Director | Stock options(+) | 4,000 | DART ↗ |
| 2025-12-03 | Kim Jeongjun | Director | Stock options(+) | 6,000 | DART ↗ |
| 2025-11-18 | Seung-Joo Lee | Vice president | Stock options(+) | 28,000 | DART ↗ |
| 2025-11-06 | Lim Hyunjin | Managing director | Stock options(+) | 4,000 | DART ↗ |
| 2025-11-06 | Heo Tae Suk | Director | Stock options(+) | 10,000 | DART ↗ |
| 2025-09-26 | Lim Hyunjin | Managing director | Stock options(+) | 6,000 | DART ↗ |
| 2025-09-24 | Lim Hyunjin | Managing director | Stock options(+) | 2,000 | DART ↗ |
| 2025-07-15 | Lim Hyunjin | Managing director | Off-hour trading(-) | 7,024 | DART ↗ |
| 2025-07-15 | Lim Hyunjin | Managing director | Off-hour trading(+) | 7,024 | DART ↗ |
| 2025-04-21 | Kim Jaeseung | Vice president | Donation(-) | 5,000 | DART ↗ |
| 2025-04-21 | Kim Jaeseung | Vice president | Donation(-) | 5,000 | DART ↗ |
| 2025-04-11 | Dongkoo Bio&Pharma Co.,Ltd | 10% shareholder | Paid-in capital increase by third-party allotment(+) | 1,344,086 | DART ↗ |
| 2025-04-02 | Kim Hyun Jung | Director | Donation(-) | 3,184 | DART ↗ |
| 2025-04-02 | Kim Hyun Jung | Director | Donation(-) | 3,100 | DART ↗ |
| 2025-04-02 | Kim Hyun Jung | Director | Donation(-) | 3,000 | DART ↗ |
| 2024-11-29 | Dongkoo Bio&Pharma Co., Ltd | 10% shareholder | 장내매수(+) | 4,039 | DART ↗ |
| 2024-11-28 | Dongkoo Bio&Pharma Co., Ltd | 10% shareholder | 장내매수(+) | 28,084 | DART ↗ |
| 2024-11-27 | Dongkoo Bio&Pharma Co., Ltd | 10% shareholder | 장내매수(+) | 3,299 | DART ↗ |
| 2024-11-26 | Dongkoo Bio&Pharma Co., Ltd | 10% shareholder | 장내매수(+) | 18,950 | DART ↗ |
| 2024-11-25 | Dongkoo Bio&Pharma Co., Ltd | 10% shareholder | 장내매수(+) | 10,400 | DART ↗ |
| 2024-11-22 | Dongkoo Bio&Pharma Co., Ltd | 10% shareholder | 장내매수(+) | 4,649 | DART ↗ |
| 2024-11-22 | Dongkoo Bio&Pharma Co., Ltd | 10% shareholder | CB인수(+) | 1,314,348 | DART ↗ |
| 2024-11-20 | Dongkoo Bio&Pharma Co., Ltd | 10% shareholder | 장내매수(+) | 15,831 | DART ↗ |
| 2024-11-19 | Dongkoo Bio&Pharma Co., Ltd | 10% shareholder | 장내매수(+) | 2,710 | DART ↗ |
| 2024-11-18 | Dongkoo Bio&Pharma Co., Ltd | 10% shareholder | 장내매수(+) | 6,400 | DART ↗ |
| 2024-11-15 | Dongkoo Bio&Pharma Co., Ltd | 10% shareholder | 장내매수(+) | 37,494 | DART ↗ |
| 2024-11-14 | Dongkoo Bio&Pharma Co., Ltd | 10% shareholder | 장내매수(+) | 9,050 | DART ↗ |
| 2024-11-13 | Dongkoo Bio&Pharma Co., Ltd | 10% shareholder | 장내매수(+) | 7,179 | DART ↗ |
| 2024-11-12 | Dongkoo Bio&Pharma Co., Ltd | 10% shareholder | 장내매수(+) | 25,260 | DART ↗ |
| 2024-09-26 | Byung Girl Rhee | Non-executive director | 신규보고(+) | 2,809 | DART ↗ |